<DOC>
	<DOCNO>NCT00831207</DOCNO>
	<brief_summary>Cross-sectional study assess behavior Beta-2 microglobulin serum cytokine TNF-α , IFN-γ , IL-2 , IL-4 IL-10 indicator highly active antiretroviral therapy ( HAART ) failure .</brief_summary>
	<brief_title>Beta-2 Microglobulin Serum Cytokines x HAART</brief_title>
	<detailed_description>Objective : To assess behavior Beta-2 microglobulin serum cytokine TNF-α , IFN-γ , IL-2 , IL-4 IL-10 indicator highly active antiretroviral therapy ( HAART ) failure Design : Cross-sectional study . Methods : Eighty-nine HIV-1+ patient 20 normal individual divide 4 group : G1- 15 HIV-1+ individual , previously untreated without HAART least six month CD4+ &lt; 350 cells/mm3 ; G2- 31 HIV-1+ individual undergo HAART without virological therapeutic failure ( TF ) , G3- 43 HIV-1+ individual undergo HAART TF , GC- 20 normal individual serve control serum cytokine . Demographic , clinical HAART data review , Beta-2 microglobulin , serum cytokine ( TNF-α , IFN-γ , IL-2 , IL-4 IL-10 ) , HIV-1 genotyping , plasma viral load CD4+ CD8+ lymphocytes test perform . Key word : Beta-2 microglobulin , serum cytokine , HIV-1 , resistance , HAART , therapeutic failure , genotyping .</detailed_description>
	<criteria>HIV1infected individual Over 18 year old Sign `` write consent form '' ( WCF ) Do present immunosuppression cause , neoplasia , transplantation Do present treatment immunosuppressive substance Do present autoimmune disease Not use type immunostimulating substance Not time gestation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>B-2 microglobulin</keyword>
	<keyword>Serum cytokine</keyword>
	<keyword>HIV-1</keyword>
	<keyword>Resistance</keyword>
	<keyword>HAART</keyword>
	<keyword>Therapeutic failure</keyword>
	<keyword>Genotyping .</keyword>
</DOC>